169 related articles for article (PubMed ID: 18543072)
1. A summary measure of pro- and anti-oxidant exposures and risk of incident, sporadic, colorectal adenomas.
Goodman M; Bostick RM; Dash C; Terry P; Flanders WD; Mandel J
Cancer Causes Control; 2008 Dec; 19(10):1051-64. PubMed ID: 18543072
[TBL] [Abstract][Full Text] [Related]
2. Hypothesis: oxidative stress score as a combined measure of pro-oxidant and antioxidant exposures.
Goodman M; Bostick RM; Dash C; Flanders WD; Mandel JS
Ann Epidemiol; 2007 May; 17(5):394-9. PubMed ID: 17462547
[TBL] [Abstract][Full Text] [Related]
3. Measures of combined antioxidant and pro-oxidant exposures and risk of overall and advanced stage prostate cancer.
Geybels MS; Verhage BA; van Schooten FJ; van den Brandt PA
Ann Epidemiol; 2012 Nov; 22(11):814-20. PubMed ID: 22986088
[TBL] [Abstract][Full Text] [Related]
4. Sporadic duodenal adenoma and the association with colorectal neoplasia: a case-control study.
Ramsoekh D; van Leerdam ME; Dekker E; Ouwendijk RT; van Dekken H; Kuipers EJ
Am J Gastroenterol; 2008 Jun; 103(6):1505-9. PubMed ID: 18510617
[TBL] [Abstract][Full Text] [Related]
5. Plasma enterolignans are associated with lower colorectal adenoma risk.
Kuijsten A; Arts IC; Hollman PC; van't Veer P; Kampman E
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1132-6. PubMed ID: 16775171
[TBL] [Abstract][Full Text] [Related]
6. Patients with sporadic duodenal adenoma are a high-risk group for advanced colorectal neoplasia: results of a case-control study.
Pequin P; Manfredi S; Quentin V; Heresbach D; Boyer J; Siproudhis L; Bretagne JF
Aliment Pharmacol Ther; 2007 Jul; 26(2):277-82. PubMed ID: 17593073
[TBL] [Abstract][Full Text] [Related]
7. Combined measure of pro- and anti-oxidant exposures in relation to prostate cancer and colorectal adenoma risk: an update.
Goodman M; Bostick RM; Gross M; Thyagarajan B; Dash C; Flanders WD
Ann Epidemiol; 2010 Dec; 20(12):955-7. PubMed ID: 21074110
[TBL] [Abstract][Full Text] [Related]
8. DNA base excision repair genetic risk scores, oxidative balance, and incident, sporadic colorectal adenoma.
Wang T; Goodman M; Sun YV; Thyagarajan B; Gross M; Bostick RM
Mol Carcinog; 2017 Jun; 56(6):1642-1652. PubMed ID: 28120344
[TBL] [Abstract][Full Text] [Related]
9. An oxidative stress score as a combined measure of the pro-oxidant and anti-oxidant counterparts in patients with coronary artery disease.
Vassalle C; Pratali L; Boni C; Mercuri A; Ndreu R
Clin Biochem; 2008 Oct; 41(14-15):1162-7. PubMed ID: 18692492
[TBL] [Abstract][Full Text] [Related]
10. Serum triglycerides and colorectal adenoma in a case-control study among cancer screening examinees (Japan).
Otani T; Iwasaki M; Ikeda S; Kozu T; Saito H; Mutoh M; Wakabayashi K; Tsugane S
Cancer Causes Control; 2006 Dec; 17(10):1245-52. PubMed ID: 17111255
[TBL] [Abstract][Full Text] [Related]
11. Oxidative balance score, colorectal adenoma, and markers of oxidative stress and inflammation.
Kong SY; Bostick RM; Flanders WD; McClellan WM; Thyagarajan B; Gross MD; Judd S; Goodman M
Cancer Epidemiol Biomarkers Prev; 2014 Mar; 23(3):545-54. PubMed ID: 24443405
[TBL] [Abstract][Full Text] [Related]
12. Oxidative balance score and risk of prostate cancer: results from a case-cohort study.
Agalliu I; Kirsh VA; Kreiger N; Soskolne CL; Rohan TE
Cancer Epidemiol; 2011 Aug; 35(4):353-61. PubMed ID: 21145797
[TBL] [Abstract][Full Text] [Related]
13. Using pathway-specific comprehensive exposure scores in epidemiology: application to oxidative balance in a pooled case-control study of incident, sporadic colorectal adenomas.
Dash C; Goodman M; Flanders WD; Mink PJ; McCullough ML; Bostick RM
Am J Epidemiol; 2013 Aug; 178(4):610-24. PubMed ID: 23639935
[TBL] [Abstract][Full Text] [Related]
14. Associations of oxidative balance-related exposures with incident, sporadic colorectal adenoma according to antioxidant enzyme genotypes.
Labadie J; Goodman M; Thyagarajan B; Gross M; Sun Y; Fedirko V; Bostick RM
Ann Epidemiol; 2013 Apr; 23(4):223-6. PubMed ID: 23290999
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein and colorectal adenoma in the CLUE II cohort.
Tsilidis KK; Erlinger TP; Rifai N; Hoffman S; Hoffman-Bolton J; Helzlsouer KJ; Platz EA
Cancer Causes Control; 2008 Aug; 19(6):559-67. PubMed ID: 18214695
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms of CYP2E1 and risk of colorectal adenomas in the Self Defense Forces Health Study.
Morita M; Tabata S; Tajima O; Yin G; Abe H; Kono S
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1800-7. PubMed ID: 18628434
[TBL] [Abstract][Full Text] [Related]
17. CYP1A2 164 A-->C polymorphism, cigarette smoking, consumption of well-done red meat and risk of developing colorectal adenomas and carcinomas.
Saebø M; Skjelbred CF; Brekke Li K; Bowitz Lothe IM; Hagen PC; Johnsen E; Tveit KM; Kure EH
Anticancer Res; 2008; 28(4C):2289-95. PubMed ID: 18751408
[TBL] [Abstract][Full Text] [Related]
18. Micronutrients and the risk of colorectal adenomas: a case-control study in São Paulo, Brazil.
Cardoso MA; Maruta LM; Kida AA; Hashimoto C; Cordeiro JA; Iriya K
IARC Sci Publ; 2002; 156():361-3. PubMed ID: 12484206
[No Abstract] [Full Text] [Related]
19. Methionine synthase A2756G polymorphism interacts with alcohol and folate intake to influence the risk of colorectal adenoma.
Yamaji T; Iwasaki M; Sasazuki S; Sakamoto H; Yoshida T; Tsugane S
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):267-74. PubMed ID: 19124508
[TBL] [Abstract][Full Text] [Related]
20. Oxidative balance scores and risk of incident colorectal cancer in a US prospective cohort study.
Dash C; Bostick RM; Goodman M; Flanders WD; Patel R; Shah R; Campbell PT; McCullough ML
Am J Epidemiol; 2015 Apr; 181(8):584-94. PubMed ID: 25693772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
